MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Post-anoxic myoclonus: Timing matters

K.G. Su, A.L. Hiller (Portland, OR, USA)

Meeting: 2016 International Congress

Abstract Number: 926

Keywords: Myoclonus: Clinical features, Myoclonus: Treatment

Session Information

Date: Tuesday, June 21, 2016

Session Title: Myoclonus

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To highlight that timing of post-anoxic myoclonus following initial anoxic injury can result in markedly different outcomes.

Background: Post-anoxic myoclonus is typically considered a poor prognostic sign. However, there is a rare form of delayed myoclonus called Lance-Adams Syndrome that can present days to weeks after the initial anoxic insult.

Methods: Case reports.

Results: Patient AD is a 32 year old man without any significant past medical history who suffered respiratory distress secondary to choking from his seatbelt during a motor vehicle accident. He was emergently intubated at the scene and was noted to be taking spontaneous breaths during transport. Shortly after arrival to the hospital, he developed whole-body myoclonic jerks. EEG did not show evidence of cortical myoclonic status epilepticus. He was trialed on multiple medications for his persistent myoclonus; including clonazepam, gabapentin, baclofen, levetiracetam, and topiramate; without notable improvement. He was discharged on comfort care measures given his persistent comatose state, and died within a week. Patient MC is a 59 year old man with a past medical history significant for polysubstance abuse, cardiomyopathy, COPD, and hepatitis C, who was found unconscious outside a bar in ventricular fibrillation with his inhaler in hand. He received approximately 20 minutes of ACLS with recovery of spontaneous circulation and was then intubated in the field. He was cooled upon arrival to the hospital, and subsequently rewarmed per protocol. He regained consciousness and was successfully extubated. About a week after his initial cardiac arrest, he developed whole-body myoclonic jerks. EEG did not show evidence of cortical myoclonic status epilepticus. He was started on valproic acid followed by levetiracetam with marked improvement of his myoclonus. He was discharged to a skilled nursing facility for rehabilitation. Currently, he is still alive a year after his cardiac arrest.

Conclusions: Lance-Adams Syndrome was first described in the 1960s, and thus far less than 150 cases have been reported. As illustrated in this case comparison, patients with Lance-Adams Syndrome develop myoclonus in a consciousness state days to weeks after initial anoxic insult, and tend to respond well to anti-epileptic medications, carrying overall a better prognosis. Therefore, timing of myoclonus onset post-anoxic brain injury should be taken into consideration when determining treatment options and prognostication.

To cite this abstract in AMA style:

K.G. Su, A.L. Hiller. Post-anoxic myoclonus: Timing matters [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/post-anoxic-myoclonus-timing-matters/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/post-anoxic-myoclonus-timing-matters/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley